Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

May 10, 2017

Study Completion Date

May 10, 2018

Conditions
Heart Failure
Interventions
DRUG

Milrinone

Administration of study medications, PK sampling and safety profile- add on haemodynamic invasive measurements if patient consents to.

Trial Locations (1)

3004

Alfred Hospital, Melbourne

All Listed Sponsors
lead

The Alfred

OTHER

NCT01956006 - Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure | Biotech Hunter | Biotech Hunter